These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis]. Ertabaklar H, Yaman Karadam S, Malatyalı E, Ertuğ S. Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960 [Abstract] [Full Text] [Related]
5. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil. da Luz Becker D, dos Santos O, Frasson AP, de Vargas Rigo G, Macedo AJ, Tasca T. Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539 [Abstract] [Full Text] [Related]
7. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States. Butler SE, Augostini P, Secor WE. Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315 [Abstract] [Full Text] [Related]
9. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro. Elwakil HS, Tawfik RA, Alam-Eldin YH, Nassar DA. Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536 [Abstract] [Full Text] [Related]
10. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity. Malla N, Kaul P, Sehgal R, Gupta I. Indian J Med Microbiol; 2011 Nov; 29(2):152-7. PubMed ID: 21654110 [Abstract] [Full Text] [Related]
11. Lack of association between Mycoplasma hominis and Trichomonas vaginalis symbiosis in relation to metronidazole resistance. Mabaso N, Tinarwo P, Abbai N. Parasitol Res; 2020 Dec; 119(12):4197-4204. PubMed ID: 33068149 [Abstract] [Full Text] [Related]
14. Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates. Korosh T, Bujans E, Morada M, Karaalioglu C, Vanden Eynde JJ, Mayence A, Huang TL, Yarlett N. Chem Biol Drug Des; 2017 Oct; 90(4):489-495. PubMed ID: 28296056 [Abstract] [Full Text] [Related]
15. Three metronidazole-resistant strains of Trichomonas vaginalis from the United States. Müller M, Meingassner JG, Miller WA, Ledger WJ. Am J Obstet Gynecol; 1980 Dec 01; 138(7 Pt 1):808-12. PubMed ID: 7004190 [Abstract] [Full Text] [Related]
16. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Crowell AL, Sanders-Lewis KA, Secor WE. Antimicrob Agents Chemother; 2003 Apr 01; 47(4):1407-9. PubMed ID: 12654679 [Abstract] [Full Text] [Related]
17. Evaluation of the in vitro activity of ceragenins against Trichomonas vaginalis. Polat ZA, Cetin A, Savage PB. Acta Parasitol; 2016 Mar 01; 61(2):376-81. PubMed ID: 27078662 [Abstract] [Full Text] [Related]
18. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates. Goodhew EB, Secor WE. Sex Transm Infect; 2013 Sep 01; 89(6):479-84. PubMed ID: 23794105 [Abstract] [Full Text] [Related]
19. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Abdel-Magied AA, El-Kholya EI, Abou El-Khair SM, Abdelmegeed ES, Hamoudaa MM, Mohamed SA, El-Tantawy NL. Parasitol Res; 2017 Nov 01; 116(11):3125-3130. PubMed ID: 28956167 [Abstract] [Full Text] [Related]